Geneva Partners’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,414
| Closed | -$388K | – | 66 |
|
|
2024
Q1 | $388K | Sell |
3,414
-721
| -17% | -$82.7K | 0.17% | 61 |
|
|
2023
Q4 | $455K | Sell |
4,135
-2,552
| -38% | -$255K | 0.25% | 58 |
|
|
2023
Q3 | $648K | Sell |
6,687
-4,694
| -41% | -$493K | 0.43% | 43 |
|
|
2023
Q2 | $1.24M | Sell |
11,381
-100
| -0.9% | -$10.7K | 0.81% | 38 |
|
|
2023
Q1 | $573K | Sell |
11,481
-2,650
| -19% | -$280K | 0.49% | 41 |
|
|
2022
Q4 | $1.55M | Sell |
14,131
-2,499
| -15% | -$259K | 1.47% | 25 |
|
|
2022
Q3 | $604K | Sell |
16,630
-1,050
| -6% | -$112K | 0.69% | 33 |
|
|
2022
Q2 | $1.92M | Sell |
17,680
-27,688
| -61% | -$3.14M | 1.89% | 22 |
|
|
2022
Q1 | $5.37M | Sell |
45,368
-11,070
| -20% | -$1.37M | 3.32% | 11 |
|
|
2021
Q4 | $7.94M | Buy |
56,438
+1,617
| +3% | +$207K | 3.77% | 6 |
|
|
2021
Q3 | $6.48M | Buy |
54,821
+8,868
| +19% | +$1.09M | 3.07% | 10 |
|
|
2021
Q2 | $5.33M | Sell |
45,953
-655
| -1% | -$76.4K | 2.44% | 15 |
|
|
2021
Q1 | $5.58M | Sell |
46,608
-2,254
| -5% | -$267K | 2.89% | 10 |
|
|
2020
Q4 | $5.35M | Sell |
48,862
-7,604
| -13% | -$827K | 2.83% | 9 |
|
|
2020
Q3 | $6.14M | Sell |
56,466
-1,015
| -2% | -$103K | 3.76% | 3 |
|
|
2020
Q2 | $5.25M | Buy |
57,481
+8,891
| +18% | +$804K | 3.68% | 2 |
|
|
2020
Q1 | $3.83M | Buy |
48,590
+12,374
| +34% | +$1.03M | 5.45% | 3 |
|
|
2019
Q4 | $3.15M | Buy |
36,216
+4,125
| +13% | +$345K | 2.17% | 19 |
|
|
2019
Q3 | $2.69M | Sell |
32,091
-1,369
| -4% | -$116K | 2.09% | 21 |
|
|
2019
Q2 | $2.81M | Sell |
33,460
-488
| -1% | -$38.4K | 2.27% | 19 |
|
|
2019
Q1 | $2.71M | Buy |
33,948
+2,910
| +9% | +$217K | 2.31% | 17 |
|
|
2018
Q4 | $2.25M | Sell |
31,038
-1,900
| -6% | -$134K | 2.6% | 13 |
|
|
2018
Q3 | $2.42M | Buy |
32,938
+225
| +0.7% | +$14.8K | 1.86% | 18 |
|
|
2018
Q2 | $2M | Sell |
32,713
-950
| -3% | -$57.6K | 1.58% | 25 |
|
|
2018
Q1 | $2.02M | Buy |
33,663
+1,200
| +4% | +$72.3K | 1.66% | 24 |
|
|
2017
Q4 | $1.85M | Buy |
32,463
+400
| +1% | +$22.2K | 1.39% | 25 |
|
|
2017
Q3 | $1.71M | Buy |
+32,063
| New | +$1.61M | 1.35% | 29 |
|
|
2016
Q2 | $1.57M | Buy |
+32,213
| New | +$1.28M | 1.4% | 30 |
|
Other funds holding ABT
Geneva Partners's ABT Position: Q2 2024 in Review
Geneva Partners sold out of Abbott (ABT) in Q2 2024, closing a stake of 3,414 shares — an estimated $388K sold.
Geneva Partners first reported a position in ABT in Q2 2016 and held it in 28 quarters. The position peaked at $7.94M in Q4 2021. 2,861 funds tracked by Wall St. Rank hold ABT as of Q2 2024.
- Geneva Partners reported no remaining Abbott position as of Q2 2024 after selling out during the quarter.
- Geneva Partners sold 3,414 Abbott shares in Q2 2024, an estimated $388K.
- Geneva Partners first reported a position in Abbott in Q2 2016 and held it in 28 quarters.
- Geneva Partners's Abbott position peaked at $7.94M in Q4 2021.
- 2,861 funds tracked by Wall St. Rank held Abbott as of Q2 2024.
Based on Geneva Partners's 13F filing for Q2 2024, filed 22 Jul 2024.